Back

C Suite Market Update - April 2014

April 2014

Overall C-level turnover for April 2014 was up only slightly (+2%) over that of April 2013. A similar small increase was seen month over month: +3% in April versus March 2014. The small overall increases in C-level turnover were impacted by a decline in CEO and CFO changes as compared to last year. Board of Director turnover was up 7% in April 2014 over April 2013.
Executive turnover activities break down as follows:

  • CEO changes, -32%   A total of 153 changes with the largest number of changes occurring in energy, drugs and banking. Last month’s changes occurred primarily in banking, drugs/biotech and metals/mining.
  • CFO changes,  -12%   A total of 167 changes with the largest number of changes occurring in drugs/biotech, energy, banking and metals/mining. Last month’s changes occurred in the same sectors.
  • Board of Directors,  +7%   A total of 495 changes with the largest number of changes occurring in drugs/biotech, chemicals and banking. Last month’s changes occurred in drugs/biotech, energy and banking
  • Overall C suite, +2%.  A total of 1398 changes with the largest number of changes occurring in drugs/biotech, banking and energy. Last month’s changes occurred in the same sectors.

Despite the declines in CEO and CFO turnover this month, the overall positive increase continues to reflect gradual improvement in the economy. With the overall improvement in employment statistics, spring and summer should show continued improvement in opportunities for top executives as well.